222 related articles for article (PubMed ID: 17904545)
1. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
Vajda S; Baczkó I; Leprán I
Eur J Pharmacol; 2007 Dec; 577(1-3):115-23. PubMed ID: 17904545
[TBL] [Abstract][Full Text] [Related]
2. Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?
Das B; Sarkar C
Life Sci; 2005 Jul; 77(11):1226-48. PubMed ID: 15964023
[TBL] [Abstract][Full Text] [Related]
3. Selective mitochondrial KATP channel activation by nicorandil and 3-pyridyl pinacidil results in antiarrhythmic effect in an anesthetized rabbit model of myocardial ischemia/reperfusion.
Das B; Sarkar C
Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):97-110. PubMed ID: 12731455
[TBL] [Abstract][Full Text] [Related]
4. Cardiomyocyte mitochondrial KATP channels participate in the antiarrhythmic and antiinfarct effects of KATP activators during ischemia and reperfusion in an intact anesthetized rabbit model.
Das B; Sarkar C
Pol J Pharmacol; 2003; 55(5):771-86. PubMed ID: 14704474
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model.
Das B; Sarkar C
Pharmacol Res; 2003 Jun; 47(6):447-61. PubMed ID: 12741997
[TBL] [Abstract][Full Text] [Related]
6. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels.
Fryer RM; Hsu AK; Nagase H; Gross GJ
J Pharmacol Exp Ther; 2000 Aug; 294(2):451-7. PubMed ID: 10900218
[TBL] [Abstract][Full Text] [Related]
7. Both mitochondrial KATP channel opening and sarcolemmal KATP channel blockage confer protection against ischemia/reperfusion-induced arrhythmia in anesthetized male rats.
Gonca E; Bozdogan O
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):403-11. PubMed ID: 20693159
[TBL] [Abstract][Full Text] [Related]
8. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs.
Billman GE; Englert HC; Schölkens BA
J Pharmacol Exp Ther; 1998 Sep; 286(3):1465-73. PubMed ID: 9732412
[TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
[TBL] [Abstract][Full Text] [Related]
10. Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels.
Rajesh KG; Sasaguri S; Suzuki R; Xing Y; Maeda H
Int J Cardiol; 2004 Jul; 96(1):41-9. PubMed ID: 15203260
[TBL] [Abstract][Full Text] [Related]
11. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
12. Effects of the cardioselective KATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion.
Gögelein H; Ruetten H; Albus U; Englert HC; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jul; 364(1):33-41. PubMed ID: 11485036
[TBL] [Abstract][Full Text] [Related]
13. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
Das B; Sarkar C; Karanth KS
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
[TBL] [Abstract][Full Text] [Related]
14. Is preconditioning by oxytocin administration mediated by iNOS and/or mitochondrial K(ATP) channel activation in the in vivo anesthetized rabbit heart?
Das B; Sarkar C
Life Sci; 2012 May; 90(19-20):763-9. PubMed ID: 22525371
[TBL] [Abstract][Full Text] [Related]
15. Evidence for mitochondrial K ATP channels as effectors of human myocardial preconditioning.
Ghosh S; Standen NB; Galiñanes M
Cardiovasc Res; 2000 Mar; 45(4):934-40. PubMed ID: 10728419
[TBL] [Abstract][Full Text] [Related]
16. Effects of the blockade of cardiac sarcolemmal ATP-sensitive potassium channels on arrhythmias and coronary flow in ischemia-reperfusion model in isolated rat hearts.
Gok S; Vural K; Sekuri C; Onur R; Tezcan A; Izanli A
Vascul Pharmacol; 2006 Apr; 44(4):197-205. PubMed ID: 16495160
[TBL] [Abstract][Full Text] [Related]
17. HMR 1883, a cardioselective K(ATP) channel blocker, inhibits ischaemia- and reperfusion-induced ventricular fibrillation in rats.
Wirth KJ; Klaus E; Englert HG; Schölkens BA; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):295-300. PubMed ID: 10543431
[TBL] [Abstract][Full Text] [Related]
18. Differential role of sarcolemmal and mitochondrial K(ATP) channels in adenosine-enhanced ischemic preconditioning.
Toyoda Y; Friehs I; Parker RA; Levitsky S; McCully JD
Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2694-703. PubMed ID: 11087223
[TBL] [Abstract][Full Text] [Related]
19. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
Tawfik MK; Abo-Elmatty DM; Ahmed AA
Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
[TBL] [Abstract][Full Text] [Related]
20. The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion.
Assad AR; Delou JM; Fonseca LM; Villela NR; Nascimento JH; Verçosa N; Lopes AG; Capella MA
Anesth Analg; 2009 Nov; 109(5):1486-92. PubMed ID: 19843786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
